No Data
Ventyx Biosciences to Participate in Three Upcoming Investor Conferences
SAN DIEGO, May 16, 2024 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (NASDAQ:VTYX) ("Ventyx"), a clinical-stage biopharmaceutical company focused on advancing novel oral therapies that address a broad range of
Ventyx Biosciences Gets New Operations Chief
Press Release: Ventyx Biosciences Announces Appointment of Matthew Moore as Chief Operating Officer
Ventyx Biosciences Announces Appointment of Matthew Moore as Chief Operating Officer SAN DIEGO, May 16, 2024 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (Nasdaq: VTYX), ("Ventyx"), a clinical-stage
Stifel Nicolaus Keeps Their Hold Rating on Ventyx Biosciences (VTYX)
Ventyx Biosciences, Inc. (NASDAQ:VTYX) Q1 2024 Earnings Call Transcript
Analysts Offer Insights on Healthcare Companies: Quantum-Si (QSI), Savara (SVRA) and Ventyx Biosciences (VTYX)